LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article: State of the art in hereditary muscle channelopathies.

    Jurkat-Rott, K / Lehmann-Horn, F

    Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology

    2011  Volume 29, Issue 2, Page(s) 343–350

    Abstract: ... channelopathies. Typical hereditary muscle channelopa thies are congenital myasthenic syndromes, non-dystrophic ... myotonias, periodic paralyses, malignant hyperthermia, and central core disease. Most muscle channelopathies ... of several skeletal muscle disorders to be caused by pathologically functioning ion channels and has led to the term ...

    Abstract A combination of electrophysiological and genetic studies has resulted in the identification of several skeletal muscle disorders to be caused by pathologically functioning ion channels and has led to the term channelopathies. Typical hereditary muscle channelopa thies are congenital myasthenic syndromes, non-dystrophic myotonias, periodic paralyses, malignant hyperthermia, and central core disease. Most muscle channelopathies are commonly considered to be benign diseases. However, life-threatening weakness episodes or progressive permanent weakness may make these diseases severe, particularly the periodic paralyses (PP). Even in the typical PP forms characterized by episodic occurrence of weakness, up to 60% of the patients suffer from permanent weakness and myopathy with age. In addition, some PP patients present with a predominant progressive muscle weakness phenotype. The weakness can be explained by strongly depolarized fibers that take up sodium and water and that are electrically inexcitable. Drugs that repolarize the fiber membrane can restore muscle strength and may prevent progression.
    MeSH term(s) Anesthetics, Local/therapeutic use ; Anti-Arrhythmia Agents/therapeutic use ; Channelopathies/drug therapy ; Channelopathies/genetics ; Diuretics/therapeutic use ; Drug Therapy/trends ; Humans ; Myasthenic Syndromes, Congenital/drug therapy ; Myasthenic Syndromes, Congenital/genetics ; Myotonia/drug therapy ; Myotonia/genetics ; Paralyses, Familial Periodic/drug therapy ; Paralyses, Familial Periodic/genetics
    Chemical Substances Anesthetics, Local ; Anti-Arrhythmia Agents ; Diuretics
    Language English
    Publishing date 2011-01-06
    Publishing country Italy
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2102328-1
    ISSN 1128-2460
    ISSN 1128-2460
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Cardiac Phenotypes in Hereditary Muscle Disorders: JACC State-of-the-Art Review.

    Arbustini, Eloisa / Di Toro, Alessandro / Giuliani, Lorenzo / Favalli, Valentina / Narula, Nupoor / Grasso, Maurizia

    Journal of the American College of Cardiology

    2018  Volume 72, Issue 20, Page(s) 2485–2506

    Abstract: ... in myotonic dystrophies and skeletal muscle channelopathies. Although the actual cardiac management is rarely based ... the predominant manifestations and the prognostic determinants of many hereditary muscle disorders. ... Hereditary muscular diseases commonly involve the heart. Cardiac manifestations encompass ...

    Abstract Hereditary muscular diseases commonly involve the heart. Cardiac manifestations encompass a spectrum of phenotypes, including both cardiomyopathies and rhythm disorders. Common biomarkers suggesting cardiomuscular diseases include increased circulating creatine kinase and/or lactic acid levels or disease-specific metabolic indicators. Cardiac and extra-cardiac traits, imaging tests, family studies, and genetic testing provide precise diagnoses. Cardiac phenotypes are mainly dilated and hypokinetic in dystrophinopathies, Emery-Dreifuss muscular dystrophies, and limb girdle muscular dystrophies; hypertrophic in Friedreich ataxia, mitochondrial diseases, glycogen storage diseases, and fatty acid oxidation disorders; and restrictive in myofibrillar myopathies. Left ventricular noncompaction is variably associated with the different myopathies. Conduction defects and arrhythmias constitute a major phenotype in myotonic dystrophies and skeletal muscle channelopathies. Although the actual cardiac management is rarely based on the cause, the cardiac phenotypes need precise characterization because they are often the only or the predominant manifestations and the prognostic determinants of many hereditary muscle disorders.
    MeSH term(s) Glycogen Storage Disease Type II/diagnostic imaging ; Glycogen Storage Disease Type II/epidemiology ; Glycogen Storage Disease Type II/genetics ; Heart Diseases/diagnostic imaging ; Heart Diseases/epidemiology ; Heart Diseases/genetics ; Humans ; Muscular Diseases/diagnostic imaging ; Muscular Diseases/epidemiology ; Muscular Diseases/genetics ; Muscular Dystrophies/diagnostic imaging ; Muscular Dystrophies/epidemiology ; Muscular Dystrophies/genetics ; Muscular Dystrophy, Duchenne/diagnostic imaging ; Muscular Dystrophy, Duchenne/epidemiology ; Muscular Dystrophy, Duchenne/genetics ; Pedigree ; Phenotype ; Review Literature as Topic
    Language English
    Publishing date 2018-11-15
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 605507-2
    ISSN 1558-3597 ; 0735-1097
    ISSN (online) 1558-3597
    ISSN 0735-1097
    DOI 10.1016/j.jacc.2018.08.2182
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top